Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-γ-dependent effector mechanisms

Journal of Immunology

Volumn 162, Issue 1, 1999, Pages 345-351

  Jankovic, Dragana ^a   Wynn, Thomas A ^a   Kullberg, Marika C ^a   Hieny, Sara ^a   Caspar, Patricia ^a   James, Stephanie ^a   Cheever, Allen W ^a,b   Sher, Alan ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CERCARIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GAMMA IRRADIATION; HOST RESISTANCE; HUMORAL IMMUNITY; INTERFERON PRODUCTION; INTRADERMAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; MALE; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SIGNAL TRANSDUCTION; VACCINATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIBODIES, HELMINTH; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GAMMA RAYS; IMMUNIZATION SCHEDULE; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; LARVA; LYMPHOCYTE ACTIVATION; LYMPHOPENIA; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; T-LYMPHOCYTES; VACCINES, ATTENUATED;

EID: 0032909393     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Bergquist, N. R., B. F. Hall, and S. L. James. 1994. Schistosomiasis vaccine development: translating basic research into practical results. Immunologist 2:131.
2. Bergquist, N. R., and D. G. Colley. 1998. Schistosomiasis vaccines: research to development. Parasitol. Today 14:99.
3. Minard, P., D. A. Dean, R. Jacobs, W. Vannier, and K. D. Murrell. 1978. Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am. J. Trop. Med. Hyg. 27:76.
4. Richter, D., D. A. Ham, and F-R. Matuschka. 1995. The irradiated cercariae vaccine model: looking on the bright side of radiation. Parasitol. Today 11:288.
5. Kelly, A. B. E., and D. G. Colley. 1988. In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni. J. Immunol. 140:2737.
6. Vignali, D. A. A., P. Crocker, Q. D. Bickle, S. Cobbold, H. Waldmann, and M. G. Taylor. 1989. A role for CD4+ but not CD8+ T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections. Immunology 67:466.
7. Sher, A., R. L. Coffman, S. Hieny, and A. W. Cheever. 1990. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J. Immunol. 145:3911.
8. Smythies, L. E., P. S. Coulson, and R. A. Wilson. 1992. Monoclonal antibody to IFN-γ modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J. Immunol. 149:3654.
9. Wilson, R. A., P. S. Coulson, C. Betts, M.-A. Dowling, and L. E. Smythies. 1996. Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-γ receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology 87:275.
10. James, S. L., P. C. Natovitz, W. L. Farrar, and E. J. Leonard. 1984. Macrophages as effector cells of protective immunity in murine schistosomiasis: macrophage activation in mice vaccinated with radiation-attenuated cercariae. Infect. Immun. 44:569.
11. James, S. L., and C. Nacy. 1993. Effector functions of activated macrophages against parasites. Curr. Opin. Immunol. 5:518.
12. James, S. L., and J. A. Glaven. 1989. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143:4208.
13. Wynn, T. A., I. P. Oswald, I. A. Eltoum, P. Caspar, C. J. Lowenstein, F. A. Lewis, S. L. James, and A. Sher. 1994. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J. Immunol. 153:5100.
14. King, C. L., I. Malhotra, and X. Jia. 1996. Schistosoma mansoni: protective immunity in IL-4-deficient mice. Exp. Parasitol. 84:245.
15. Sher, A., R. Correa-Oliviera, S. Hieny, and R. Hussain. 1983. Mechanism of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. IV. Analysis of the role of IgE antibodies and mast cells. J. Immunol. 131:1460.
16. King, C. L., J. Xianli, I. Malhotra, S. Liu, A. A. F. Mahmoud, and H. C. Oettgen. 1997. Mice with targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni. J. Immunol. 158:294.
17. Sher, A., S. Hieny, S. L. James, and R. Asofsky. 1982. Mechanism of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes, or complement. J. Immunol. 128:1880.
18. Ron, Y., B. P. De, J. Gordon, M. Feldman, and S. Segal. 1981. Defective induction of antigen-reactive proliferating T cells in B cell deprived mice. Eur. J. Immunol. 11:964.
19. Sacks, D. L., P. A. Scott, R. Asofsky, and F. A. Sher. 1984. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J. Immunol. 132:2072.
20. Bickle, Q. D., B. J. Andrews, M. J. Doenhoff, M. J. Ford, and M. G. Taylor. 1985. Resistance against Schistosoma mansoni induced by highly irradiated infections: studies on species specificity of immunization and attempts to transfer the resistance. Parasitology 90:301.
21. Mangold, B. L., and D. A. Dean. 1986. Passive transfer with serum and IgG antibodies of irradiated cercaria-induced resistance against Schistosoma mansoni in mice. J. Immunol. 136:2644.
22. Delgado, V., and D. J. McLaren. 1990. Evidence for enhancement of IgG1 subclass expression in mice polyvaccinaled with radiation-attenuated cercariae of Schistosoma mansoni and the role of this isotype in serum-transferred immunity. Parasite Immunol. 12:15.
23. Caulada-Benedetti, Z., F. Al-Zamel, A. Sher, and S. L. James. 1991. Comparison of Th1 - and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosomas mansoni cercariae. J. Immunol. 153:5200.
24. Kitamura, D., J. Roes, R. Kühn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350:423.
25. Epstein, M. M., F. Di Rosa, D. Jankovic, A. Sher, and P. Matzinger. 1995. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182:915.
26. + T cells to protein antigens in vivo. J. Immunol. 155:3734.
27. Baird, A., and D. C. Parker. 1996. Analysis of low zone tolerance induction in normal and B cell-deficient mice. J. Immunol. 157:1833.
28. + T cell activation and tolerance induction in B cell knockout mice. J. Exp. Med. 183:1339.
29. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J. V. Ravetch. 1994. FcR γ chain deletion results in pleiotropic effector cell defects. Cell 76:519.
30. Dalton, D. K., M. S. Pitts, S. Keshav, I. S. Figari, A. Brandley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferongamma genes. Science 259:1739.
31. Scharton-Kersten, T. M., T. A. Wynn, E. Y. Denkers, S. Bala, E. Grunvald, S. Hieny, R. T. Gazzinelli, and A. Sher. 1996. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045.
32. Sher, A., E. Pearce, S. Hieny, and James, S. L. 1986. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. IV. Fractionation and antigenic properties of a soluble adult worm immunoprophylactic activity. J. Immunol. 136:3878.
33. Smithers, S. R., and R. J. Terry. 1965. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of adult worms. Parasitology 55:659.
34. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149:175.
35. Wynn, T. A., A. Reynolds, S. James, A. W. Cheever, P. Caspar, S. Hieny, D. Jankovic, M. Strand, and A. Sher. 1996. Interleukin-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell mediated immune responses against the parasite. J. Immunol. 157:4068.
36. Scott, P., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immuno-regulation of cutaneous leishmaniasis: T cell lines that transfer immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 68:1675.
37. Mosmann, T. R., J. H. Schumacher, D. F. Fiorentino, H. Leverah, K. W. Moore, and M. W. Bond. 1990. Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunosorbent assay. J. Immunol. 145:2938.
38. Hu-Li, J., J. Ohara, C. Watson, W. Tsang, and W. E. Paul. 1989. Derivation of a T cell line that is highly responsive to IL-4 and IL-2 (CT. 4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol 142:800.
39. Kullberg, M. C., J. A. Berzofsky, D. L. Jankovic, S. Barbieri, M. E. Williams, P. Perlmann, A. Sher, and M. Troye-Blomberg. 1996. T-cell-derived IL-3 induces the production of IL-4 by non-B, non-T cells to amplify the Th2-cytokine response to a non-parasite antigen in Schistosoma mansoni-infected mice. J. Immunol. 156:1482.
40. + T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J. Exp. Med. 187:619.
41. Williams, M. E., P. Caspar, I. Oswald, H. Sharma, O. Pankewycz, A. Sher, and S. L. James. 1995. Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-β, which down-regulates macrophage antiparasitic activity. J. Immunol. 154:4700.
42. + T cells. Immunol Rev. 123:209.
43. Correa-Oliviera, R., A. Sher, and S. L. James. 1984. Mechanism of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. Am. J. Trop. Med. Hyg. 33:261.
44. Rihet, P., C. E. Demeure, A. Bourgois, A. Prata, and A. J. Dessein. 1991. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur. J. Immunol. 21:2679.
45. Dunne, D. W., A. E. Butterworth, A. J. C. Fulford, H. C. Kariuki, J. G. Langley, J. H. Ouma, A. Capron, R. J. Pierce, and R. F. Sturrock. 1992. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur. J. Immunol. 22:1438.
46. Takechi, Y., Y. Moroi, A. Houghton, and J. V. Ravetch. 1998. Fc receptors are required in passive and active immunity to melanoma. Proc. Natl. Acad. Sci. USA 95:652.
47. James, S. L., A. Sher, J. K. Lazdins, M. S. Meltzer. 1982. Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula by macrophages activated as a consequence of Schistosoma mansoni infection. J. Immunol. 128:1535.
48. Wynn, T. A., D. Jankovic, S. Hieny, A. W. Cheever, and A. Sher. 1995. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue cosinophilia. J. Immunol. 154:4701.
49. Jankovic, D., P. Caspar, M. Zweig, M. Garcia-Moll, S. D. Showalter, F. R. Vogel, and A. Sher. 1997. Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120. J. Immunol. 159:2409.
50. Germann, T., M. Bongartz, H. Dlugonska, H. Hess, E. Schmitt, L. Koble, E. Kölsch, F. J. Podlanski, M. K. Gately, and E. Rüde. 1995. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b, and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25:823.